aspartic acid has been researched along with Tauopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Miao, Y; Sun, A; Zhang, Q; Zhang, X | 1 |
| Combs, B; Gamblin, TC; Voss, K | 1 |
2 other study(ies) available for aspartic acid and Tauopathies
| Article | Year |
|---|---|
Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies.
Topics: Animals; Aspartic Acid; Caspase 3; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; tau Proteins; Tauopathies | 2009 |
Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.
Topics: Amino Acid Substitution; Arachidonic Acid; Aspartic Acid; Biopolymers; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mutagenesis, Site-Directed; Phosphorylation; Protein Isoforms; Serine; tau Proteins; Tauopathies; Threonine | 2011 |